In the BioHarmony Drug Report Database

"Preview" Icon

Vaborbactam

Vabomere, Vaborem (vaborbactam) is a small molecule pharmaceutical. Vaborbactam was first approved as Vabomere on 2017-08-29. It is used to treat bacterial infections in the USA. It has been approved in Europe to treat bacteremia, bacterial infections, pneumonia, respiratory tract infections, and urinary tract infections amongst others. Vabomere’s patents are valid until 2031-08-29 (FDA).

 

Trade Name

 

Vaborem
 

Common Name

 

vaborbactam
 

ChEMBL ID

 

CHEMBL3317857
 

Indication

 

bacteremia, bacterial infections, pneumonia, respiratory tract infections, urinary tract infections, ventilator-associated pneumonia
 

Drug Class

 

Beta-lactamase inhibitors

Image (chem structure or protein)

Vaborbactam structure rendering